2018年3月 - 现在
Leading a relentless team of analysts that support and guide corporate initiatives of a leading cancer diagnostics laboratory aimed at performing nearly 1 million tests this year. Managing a high throughput SDLC with team members in
5 countries. Promoting a strong focus on team development through continued education.
Notable projects include :
. Genoptix Acquisition - Actively integrating people, processes, and systems in support of the recent acquisition
of Genoptix Working to onboard and cross-train 3 additional analysts. Identifying best practices and synergies
to leverage as we standardize and combine two large scale laboratories.
. FDA NGS Panel Submission - Point person in IT for next-generation sequencing projects including the design
and submission of a multi-gene NGS panel. knowledge bridge between Communication and Project
Management, Molecular Operations, Bioinformatics, and Information Technology departments. Functional
PROJECT DETAILS in environments governed by GAMP guidelines and 21 CFR Pt.11 regulations.
. NGS Reporting and Operational Overhaul - Managed efforts to redesign our flagship multi-methodology panel
report design. Negotiated improved contract for outsourced clinical trial and therapy matching. Improved
preliminary resulting throughput by 400% through batch reporting and automation. Bringing computational and
variant calling services in-house with an estimated annual cost savings of over $900k.
. HER2 Workflow Redesign - Designed and implemented a new operational and systematic workflow to comply
with ASCO/CAP guideline updates. Managed changes to intertwined operational departments as well as
reporting processes for internal and external Pathologists.
. NeoCOMPLETE Product Launch - Provided project management and IT insights on the creation and launch of a
new multi-methodology hematological evaluation. Enhanced system reporting capabilities to automatically
integrate the results of flow cytometry, morphology, cytogenetics, FISH, and molecular testing Sanger, PCR, and
NGS .